Stem Cell Therapy

Umbilical Cord Blood Stem Cell: Source & Uses

How umbilical cord blood stem cells are collected at birth, cryopreserved, screened, and used as an allogeneic source of hematopoietic and mesenchymal stem cells at Stem Cell Care India.

Umbilical Cord Blood Stem Cell India 16+ years, trusted care
4.9★ from 196+ verified patients
10,000+Patients treated
65+Countries served
4.9/5196+ verified reviews
CertifiedAccredited hospitals & labs
16+ YearsGMP-certified cell processing

Key takeaways

  • Umbilical cord blood is the residual blood left in the umbilical cord and placenta after birth, collected painlessly and with no risk to mother or baby.
  • It is rich in hematopoietic stem cells, along with a smaller population of mesenchymal stem cells, and is collected without any invasive procedure on the donor.
  • Cord blood units are screened, HLA-typed, and cryopreserved in liquid nitrogen, where they remain viable for many years until needed.
  • At Stem Cell Care India, cord blood and cord tissue are used allogeneically, only from consented and appropriately screened sources.

Umbilical Cord Blood Stem Cells — Quick Facts

Quick facts about umbilical cord blood stem cells and how they are used
AspectWhat to know
SourceResidual blood in the umbilical cord and placenta after birth
Collection methodPainless needle draw after cord clamping; no risk to mother or baby
Cell typePredominantly hematopoietic stem cells, with some mesenchymal stem cells
Used in our treatments?Yes — used allogeneically, from consented and screened sources

How Umbilical Cord Blood Is Collected

Painless, post-birth collection of blood that would otherwise be discarded.

Umbilical cord blood is collected immediately after a baby is born, once the umbilical cord has been clamped and cut. The blood remaining in the cord and placenta — typically discarded as medical waste — is drawn off with a needle into a sterile collection bag, a process that takes only a few minutes and carries no risk to the mother or the newborn. The collected unit is screened for infectious disease, tested and HLA-typed, then processed to concentrate its stem cell content, mixed with a cryoprotectant, and stored in vapor-phase liquid nitrogen at around -196°C, where it can remain viable for years until it is needed for treatment.

01

Why Cord Blood Is a Valuable Stem Cell Source

A non-invasive, readily banked source used allogeneically under strict screening.

  • Collection involves no procedure on the donor at all — the blood is drawn from tissue that would otherwise be discarded after a routine delivery
  • Cord blood is naturally rich in hematopoietic stem cells and carries a lower risk of graft-versus-host complications than some other allogeneic sources, along with a smaller mesenchymal stem cell population
  • Because it is cryopreserved shortly after collection, a screened and typed unit can be available on relatively short notice compared with sourcing a fresh donor
  • Every allogeneic unit used at Stem Cell Care India comes from a consented, infectious-disease-screened donor and is processed under the same GMP standards as autologous cell products; see production of stem cells
Not sure where to start?Get a free, physician-reviewed opinion on your specific condition.

Frequently Asked Questions

What patients ask about umbilical cord blood stem cells.

Umbilical cord blood is collected immediately after a baby is born and the umbilical cord is clamped and cut. The residual blood remaining in the cord and placenta, which would otherwise be discarded, is drawn off with a needle into a collection bag. The process is painless and poses no risk to the mother or baby.

Cord blood is rich in hematopoietic stem cells (HSCs), the cells that give rise to red blood cells, white blood cells, and platelets, along with a smaller population of mesenchymal stem cells. It does not require invasive collection from the donor, unlike bone marrow or adipose tissue.

Cord blood units are typically allogeneic — collected from a consenting donor at birth, screened for infectious disease, HLA-typed, and cryopreserved in a cord blood bank until needed. At Stem Cell Care India, allogeneic cord blood or cord tissue is used only from consented, appropriately screened sources.

After collection and screening, cord blood units are processed to concentrate the stem cell fraction, mixed with a cryoprotectant, and stored in vapor-phase liquid nitrogen tanks at approximately -196°C, where they can remain viable for many years until required for treatment.

Some do. Patients reading about cord-blood-derived stem cells sometimes also ask about Exosome Therapy for Retinal Detachment, since vision loss from a detached retina is one area where exosome-based options are considered alongside standard protocols.

They're related but distinct. This page covers cord-blood-derived stem cells, while Exosome Therapy for Retinopathy is a condition-specific treatment page for patients dealing with retinal blood-vessel damage, often diabetes-related; the clinical team can advise on how the two fit together.

This page focuses on cord-blood-derived stem cells, not on any one condition. For nerve pain and numbness from diabetes, see the dedicated Exosome Therapy for Diabetic Neuropathy page.

It can be. Exosome Therapy for Muscular Dystrophy is a separate regenerative option some patients researching progressive muscle weakness look into alongside umbilical cord blood stem cell therapy, assessed case-by-case during a free medical evaluation.

Some do. Patients reading about cord-blood-derived stem cells sometimes also ask about Exosome Therapy for Osteoporosis, since low bone density and fracture risk is one area where exosome-based options are considered alongside standard protocols.

They're related but distinct. This page covers cord-blood-derived stem cells, while Exosome Therapy for Parkinson’s Disease is a condition-specific treatment page for patients dealing with tremor, rigidity, and movement symptoms; the clinical team can advise on how the two fit together.

This page focuses on cord-blood-derived stem cells, not on any one condition. For autoimmune joint inflammation, see the dedicated Exosome Therapy for Rheumatoid Arthritis page.

It can be. Exosome Therapy for Sciatic Nerve Injury & Sciatica is a separate regenerative option some patients researching sciatic nerve pain radiating down the leg look into alongside umbilical cord blood stem cell therapy, assessed case-by-case during a free medical evaluation.

Some do. Patients reading about cord-blood-derived stem cells sometimes also ask about Exosome Therapy for Shoulder Injury, since rotator cuff and shoulder joint damage is one area where exosome-based options are considered alongside standard protocols.

They're related but distinct. This page covers cord-blood-derived stem cells, while Exosome Therapy for Spinal Cord Injury is a condition-specific treatment page for patients dealing with loss of motor or sensory function after cord damage; the clinical team can advise on how the two fit together.

This page focuses on cord-blood-derived stem cells, not on any one condition. For motor-neuron loss and progressive weakness in SMA, see the dedicated Exosome Therapy for Spinal Muscular Atrophy page.

It can be. Exosome Therapy for Sports Injuries is a separate regenerative option some patients researching soft-tissue and joint injuries from athletic activity look into alongside umbilical cord blood stem cell therapy, assessed case-by-case during a free medical evaluation.

Some do. Patients reading about cord-blood-derived stem cells sometimes also ask about Exosome Therapy for Systemic Lupus, since autoimmune inflammation affecting multiple organs is one area where exosome-based options are considered alongside standard protocols.

They're related but distinct. This page covers cord-blood-derived stem cells, while Exosome Therapy for Wound Healing is a condition-specific treatment page for patients dealing with slow-healing or chronic wounds; the clinical team can advise on how the two fit together.

Want the science explained for your specific case? Send your diagnosis and reports and our medical team will explain how the research applies to you — free, no obligation.
About this guide: This page is written, reviewed, and medically approved as credited above. Content reflects the investigational status of stem cell and exosome applications under India's National Ethical Guidelines for Biomedical and Health Research (ICMR, 2017) and is not a substitute for individualized medical advice. See our full treatment disclaimer for details.

Keep exploringEpidural Stimulation Treatment: How It Works for Select Spinal Cord Injury CasesSpinal Cord Injury Walking Track: A Structured Mobility Program5 Myths About Stem Cells: What Science Actually SaysAbout Your Condition: How We Review Your CaseAdverse Effects of Stem Cell Therapy: What's Reported

On Stem Cell Care India

Explore related topics

More depth on the subjects covered in this guide.

Umbilical Cord Stem Cell Therapy

How consented cord-derived cells are used in treatment.

Mesenchymal Stem Cell Therapy

The most-studied adult stem cell type explained.

Why Mesenchymal Stem Cells

Why MSCs are the default cell choice.

Production of Stem Cells

How cells are sourced, isolated, and GMP-processed.

Types of Stem Cells

Embryonic, adult, and iPSC stem cells compared.

Sources of Adult Stem Cells

Bone marrow, fat, blood, and cord tissue compared.

Stem Cell Therapy Glossary

Every key term defined in plain English.

The Body's Stem Cell Bank Account

Where the body keeps its stem cell reserve, and how it's drawn on.

Still have a question?

Every case is different. A free medical evaluation gets you a direct, physician-reviewed answer for your specific condition — typically reviewed within about 7 working days.

Talk to a case coordinator about your specific condition and treatment options.

24–48hFrom sending your reports to a doctor-reviewed answer
10,000+Patients treated across 65+ countries
4.9 / 5From 196+ verified Google reviews

Sources & Further Reading

Independent public sources for checking the evidence yourself. The PubMed and ClinicalTrials.gov links open live database searches, so results update as new research is published. Listing a source here is not an endorsement of any treatment.